Latest Ratings for FOLD
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Feb 2022 | SVB Leerink | Maintains | Outperform | |
| Jan 2022 | SVB Leerink | Upgrades | Market Perform | Outperform |
| Jan 2022 | Cantor Fitzgerald | Maintains | Overweight |
A Closer Look at 8 Analyst Recommendations For Amicus Therapeutics
